Endothelin and ischaemic arrhythmias-antiarrhythmic or arrhythmogenic?

Cardiovascular Research

Volumn 39, Issue 3, 1998, Pages 625-632

  Sharif, Isam ^a   Kane, Kathleen A ^a   Wainwright, Cherry L ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Anaesthetised rats; BQ123; Endothelin 1; PD161721; Ventricular arrhythhmias

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; ARTICLE; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; ARRHYTHMIA; BLOOD PRESSURE; DIOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENDOTHELINS; MALE; MYOCARDIAL ISCHEMIA; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; TIME FACTORS; VENTRICULAR PREMATURE COMPLEXES;

EID: 0032168356     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00150-3     Document Type: Article

References (22)

1. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology and phathophysiology. Pharmacol Rev. 46:1994;325-415.
2. Hori S., Komatsu Y., Shigemoto R., Mizuno N., Nakanishi S. Distinct tissue distribution and cellular location of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinol. 130:1992;1885-1895.
3. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun. 186:1992;867-873.
4. Molenaar P., O'Reilly G., Sharkey A.et al. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res. 72:1993;526-538.
5. Horkay F., Laine M., Szokodi I.et al. Human pericardial fluid contains the highest amount of endothelin-1 of all mammalian biological fluids thus far tested. J Cardiovasc Pharmacol. 26(suppl 3):1995;S502-S504.
6. Brunner F., Dutoit E.F., Opie L.H. Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts. J Mol Cell Cardiol. 24:1992;1291-1305.
7. Watanabe T., Suzuki N., Shimamoto N., Fujino M., Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res. 69:1991;370-377.
8. Kusumoto K., Awane V., Fujiwara A., Watanabe T. Role of endogenous endothelin in the extension of rabbit myocardial infarction. J Cardiovasc Pharmacol. 22(suppl 8):1993;S339-S342.
9. Grover G.J., Dzwonczyk S., Parham C.S. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res. 27:1993;1613-1618.
10. Kojima M., Kusumoto K., Fujiwara S., Watanabe T., Fujino M. Role of endogenous endothelin in the extension of myocardial infarct size, studied with the endothelin receptor antagonist, TAK-044. J Cardiovasc Pharmacol. 26(suppl 3):1995;S365-S368.
11. Wang Q.D., Li X.S., Lundberg J.M., Pernow J. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemia and reperfusion injury in the pig. Cardiovasc Res. 29:1995;805-812.
12. A receptor antagonist, BQ-123, on ischaemic arrhythmias in anaesthetized rats. J Cardiovasc Pharmacol. 25:1995;634-642.
13. Vitola J.C., Forman M.B., Holsinger J.P.et al. Role of endothelin in a rabbit model of acute myocardial infarction: Effects of receptor antagonists. J Cardiovasc Pharmacol. 28:1996;774-783.
14. Yorikane R., Koike H. The arrhythmogenic action of endothelin in rats. Jpn J Pharmacol. 53:1990;259-263.
15. Hide E.J., Piper J., Thiemermann C. Endothelin-1-induced reduction of myocardial infarct size by activation of ATP-sensitve potassium channels in a rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol. 116:1995;2597-2602.
16. Wang P., Gallagher K.P., Downey J.M., Cohen M.V. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol. 28:1996;579-588.
17. ATP channels in the isolated rat heart. Cardiovas Res. 32:1996;920-929.
18. B antagonist. FASEB, 1996;10:3808 (Abstract).
19. A receptor. Life Sci. 50:1992;247-255.
20. Clark C., Foreman K.I., Kane K.A., McDonald F.M., Parrat J.R. Coronary artery ligation in anaesthetised rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Method. 3:1980;357-368.
21. Walker M.J.A., Curtis M.J., Hearse D.J.et al. The Lambeth Conventions: Guidlines for the study of arrhythmias in ischaemia, infarction and reperfusion. Cardiovas Res. 22:1988;447-455.
22. Wang Q.D., Li X.S., Pernow J. Characterization of endothelin-1-induced vascular effects in the rat heart by using endothelin receptor antagonists. Eur J Pharmacol. 271:1994;25-30.